SkinMedica Launches TNS Essential... (d 92% rated their skin as looking health...)

SkinMedica Launches TNS Essential Serum(TM)

Date:11/6/2008

d 92% rated their skin as looking healthier and more youthful. In addition, TNS Essential Serum demonstrated statistically significant improvements in the following physician-evaluated clinical endpoints:

-- Textural roughness

-- Fine and coarse wrinkles

-- Skin radiance and elasticity

-- Protection from UV exposure and resulting skin damage

TNS Essential Serum is available exclusively at doctor's offices and medically supervised spas. Visit http://www.skinmedica.com to find a location.

About SkinMedica

SkinMedica is a privately held specialty company marketing both prescription and aesthetic products that improve the appearance of skin and treat dermatologic conditions and diseases. SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz(R) Micro Cream and NeoBenz(R) Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of clinical skin care products, which is sold through physicians, includes TNS Recovery Complex(R) with NouriCel-MD(R) to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit http://www.skinmedica.com.

SkinMedica(R), Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro, NouriCel-MD(R), TNS Recovery Complex(R), and VANIQA(R) are registered trademarks of SkinMedica, Inc.

CONTACT INFORMATION:

Erin McNally

Shop PR

(212) 829-1111 x192

SOURCE SkinMedica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3
Related biology technology :

1. Genesis Pharmaceuticals Launches New Corporate Website
2. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
3. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
4. Mattel Childrens Hospital UCLA launches program in nanopediatrics
5. DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus
6. WeissComm Launches Invigorate Communications to Help Companies Build Successful Health-Based Brands
7. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
8. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
9. Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
10. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
11. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents

Post Your Comments:

(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx

(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,

(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering

(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We

[0] Martek to Announce Fourth Quarter and Fiscal Year 2009 Results [0] Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities [0] Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option [0] Gamida Cell Announces Feasibility Study With Weill Cornell Medical College

...esented at National Department of Labor Conference...nce,received the U.S. Department of Labor,s Recogn...ating America,s Workforce to Serve Emerging,Indust...loyment and,Training, Brent R. Orrell, presented t...programs from around the country that have achieve...

...Shandong, China, July 30 /Xinhua-PRNewswire-FirstC...n Board: CBPO) ("CBP," or the,"Company"), one of t...n the,People,s Republic of China ("PRC"), today an...inted Mr. Sean Shao, Dr. Jie Gan, and Dr. Tong-Jun... of Directors, and that it,has established an Audi...

...O, July 30 Neurocrine Biosciences,Inc. (Nasdaq: ...he quarter,ended June 30, 2008. For the second qua...21.0 million, or $(0.55) per share compared with a...for the same period in 2007. For the,six months, t...r $(1.10),per share, as compared to $52.1 million,...

Workforce Alliance Receives U.S. Labor Department's Excellence Award China Biologic Products Establishes Audit Committee and Appoints Three New Independent Directors to Board of Directors Neurocrine Biosciences Reports Second Quarter 2008 Results

(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N

(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re

(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today

Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6 VAI researchers find long awaited key to creating drought resistant crops 2 VAI researchers find long awaited key to creating drought resistant crops 3 Forest deal at Copenhagen must avoid creating 'carbon refugees' 2 Thomson Reuters Survey 3A Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 62501 1 Thomson Reuters Survey 3A Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 62501 2 Lombardis Shields leads special journal focused on tobacco research 62500 1 Lombardis Shields leads special journal focused on tobacco research 62500 2 Acculturation affects smoking cessation success among Latinos 10972 1 Acculturation affects smoking cessation success among Latinos 10972 2

[0] AGU fall meeting: Preliminary press conference topics, press pre-registration deadline [0] VAI researchers find long awaited key to creating drought resistant crops [0] Forest deal at Copenhagen must avoid creating 'carbon refugees'

...- The Damon Runyon Cancer Research Foundation name... Scientific Advisory Committee review. The recipi...standing postdoctoral scientists conducting basic ...ies of leading senior investigators across the cou...encourage the nation,s most promising young invest...

...2007 (Aliso Viejo, California) Ossur, an emerging...llowing several acquisitions and a period of integ... Trauma has published the long-awaited results of ...Mayo Clinic. The study, Range-of-Motion Restrictio... Four Cervical Collars, finds that Ossurs products...

...nto the way in which parasites interact with each ...are likely to break out. , A group of scientists...our of infectious parasites in rabbits. The findin...cessfully when infectious cyclical diseases in hum... Universitys School of Biosciences, University of ...

Other Biology News:Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators 2 Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators 3 Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators 4 Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure 2 Can interacting pathogens explain disease patterns? 2

Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators Mayo Clinic study: Ossur's collars superior in immobilization and reduction of pressure Can interacting pathogens explain disease patterns?

Propidium Iodide Solution [3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide] from CHEMICON

...e complete ready-to-use reagents for the isolation... formulated for the isolation of genomic DNA from ...ated for the isolation of genomic DNA from plants....used for restriction endonuclease digestion Southe...

Propidium Iodide from GeneTex

Death Check III Assay System (Caspase/Cell Viability) from Promega

Biology Products:

Propidium Iodide Solution [3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide] from CHEMICON Plant DNAzol Reagent from Invitrogen Propidium Iodide from GeneTex Death Check III Assay System (Caspase/Cell Viability) from Promega

SkinMedica Launches TNS Essential...(d 92% rated their skin as looking health...)